NFKB1 and glioma: This decreased viability of glioma cells is also possible via SMAD4-induced negative regulation of NF-κB pathway in microglia, since recent studies have shown that SMAD4 knockdown in microglia induced pro-inflammatory cytokine, IL-6 in an NF-κB dependent manner [57].